These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 523359)

  • 41. Combination antifungal therapy: where are we now, and where are we going?
    Marr K
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):24-9. PubMed ID: 15651179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
    Brogden RN; Goa KL; Coukell AJ
    Drugs; 1998 Sep; 56(3):365-83. PubMed ID: 9777313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF.
    Sionov E; Mendlovic S; Segal E
    J Antimicrob Chemother; 2005 Sep; 56(3):594-7. PubMed ID: 16006446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [In-vitro and in-vivo activity of itraconazole].
    Van Cutsem J
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():5-8. PubMed ID: 1663204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The activity of systemic antimycotic drug combinations].
    Viudes A; Pemán J; Cantón E; López-Ribot J; Gobernado M
    Rev Esp Quimioter; 2001 Mar; 14(1):30-9. PubMed ID: 11376347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal Infection.
    Choi JW; Lee KT; Kim S; Lee YR; Kim HJ; Seo KJ; Lee MH; Yeon SK; Jang BK; Park SJ; Kim HJ; Park JH; Kim D; Lee DG; Cheong E; Lee JS; Bahn YS; Park KD
    J Med Chem; 2021 Nov; 64(21):15912-15935. PubMed ID: 34662122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [New pharmaceuticals in systemic mycoses (author's transl)].
    Plempel M
    Z Hautkr; 1981 Sep; 56(17):1109-25. PubMed ID: 7293300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Voriconazole versus amphotericin B in cancer patients with neutropenia.
    Jørgensen KJ; Gøtzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New therapies for fungal pneumonia.
    Maertens J; Meersseman W; Van Bleyenbergh P
    Curr Opin Infect Dis; 2009 Apr; 22(2):183-90. PubMed ID: 19276884
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The value of amphotericin B in the treatment of invasive fungal infections.
    Klepser M
    J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of systemic fungal infections: alternatives to itraconazole.
    Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antimycotic chemotherapy in weakened resistance].
    Wegmann T
    Immun Infekt; 1984 Aug; 12(4):181-5. PubMed ID: 6480026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic Antifungal Agents: Current Status and Projected Future Developments.
    Seyedmousavi S; Rafati H; Ilkit M; Tolooe A; Hedayati MT; Verweij P
    Methods Mol Biol; 2017; 1508():107-139. PubMed ID: 27837500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of beta-1,3-glucanase in postmeiotic microspore release.
    Stieglitz H
    Dev Biol; 1977 May; 57(1):87-97. PubMed ID: 863114
    [No Abstract]   [Full Text] [Related]  

  • 55. Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
    Defaveri J; Salazar MH; Rinaldi MG; Graybill JR
    Am Rev Respir Dis; 1990 Sep; 142(3):512-5. PubMed ID: 2202244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antifungal agents used in systemic mycoses. Activity and therapeutic use.
    Graybill JR; Craven PC
    Drugs; 1983 Jan; 25(1):41-62. PubMed ID: 6297871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of antifungal combination therapy].
    Perez Diaz CE
    Drugs Today (Barc); 2010 Apr; 46 Suppl C():47-50. PubMed ID: 20490382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antimycotic therapy].
    Schaffner A
    Ther Umsch; 1990 Aug; 47(8):664-9. PubMed ID: 2218968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antifungal resistance in pathogenic fungi.
    Perea S; Patterson TF
    Clin Infect Dis; 2002 Nov; 35(9):1073-80. PubMed ID: 12384841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antifungal PK/PD considerations in fungal pulmonary infections.
    Lepak AJ; Andes DR
    Semin Respir Crit Care Med; 2011 Dec; 32(6):783-94. PubMed ID: 22167406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.